Fig. 1. NASH and fibrosis develop late in mice fed an HFD.

Slides:

Advertisements

Similar presentations

The involvement of ginseng berry extract in blood flow via regulation of blood coagulation in rats fed a high-fat diet Min Hee Kim, Jongsung Lee, Sehyun.

Advertisements

Volume 66, Issue 5, Pages (May 2017)

Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice

Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung Journal of Ginseng Research

Volume 133, Issue 2, Pages (August 2007)

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.

Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.

The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.

Fig. 3. Features of PH in KRasLA2 transgenic mice.

AAV8‐hAAT‐FGF21 treatment improves liver fibrosis

Preoperative dietary restriction reduces intimal hyperplasia and protects from ischemia- reperfusion injury Christine R. Mauro, MD, Ming Tao, MD, Peng.

Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. (A–C)

Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 4. NASH-driven fibrosis is partly TGF-β–dependent.

Fig. 3. Obese IFN-γ−/− mice develop accelerated NAFLD with fibrosis.

Volume 22, Issue 1, Pages (July 2015)

Fig. 1 Localized treatment of TNBC cancers kills tumor cells and minimizes the metastatic burden. Localized treatment of TNBC cancers kills tumor cells.

Fig. 6. N95BA5 biocompatibility beyond intended use frame.

Fig. 8. In vivo suppression of MM by CMLD

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 4. Prion infectivity of skin samples from sCJD patients.

Fig. 4. Characterization of human liver seed graft morphology.

Fig. 2. GPC3 expression in normal and tumor tissues.

Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.

Fig. 1. Paclitaxel delays tumor growth and promotes infiltration of TIE2hi/VEGFhi macrophages and TMEM assembly. Paclitaxel delays tumor growth and promotes.

TFE3 prevents diet‐induced obesity and metabolic syndrome

Fig. 8. Therapeutic effects of the transplantation of hiPSC-EPO–producing cells on renal anemia in adenine-treated mice. Therapeutic effects of the transplantation.

Fig. 5. Vascularization of human liver seed grafts.

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Fig. 1. IS mediates a hyperthrombotic uremic phenotype in an AHR-dependent manner across CKD stages. IS mediates a hyperthrombotic uremic phenotype in.

Fig. 2. Effects of SFN in mouse hepatocytes and in rat models of diet-induced glucose intolerance. Effects of SFN in mouse hepatocytes and in rat models.

Fig. 5 Combination intravenous reovirus and checkpoint inhibition in an orthotopic syngeneic brain tumor model. Combination intravenous reovirus and checkpoint.

Type 1 immunity drives metabolic disease but protects against NAFLD

Fig. 2 STED microscopy of isolated cardiomyocytes from mice treated with MP-rhodamine–loaded CaPs. STED microscopy of isolated cardiomyocytes from mice.

Fig. 6. Safety assessment in cynomolgus monkey.

Fig. 6 pDCs infiltrate the skin of BLM-treated mice, and their depletion attenuates skin fibrosis. pDCs infiltrate the skin of BLM-treated mice, and their.

Fig. 5. MMP-7 expression in human liver, EHBD, and gallbladder.

Fig. 4. Expression of HGF in liver ECs cooperates with NOX4 inhibition to enhance engraftment of regenerative hepatocytes. Expression of HGF in liver ECs.

Fig. 4. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in vivo. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in.

Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis.

Fig. 5. Accelerated NASH-driven fibrogenesis in obese IFN-γ−/− mice is characterized by severe eosinophilic inflammation during TGF-β blockade. Accelerated.

Fig. 5 EGFR mutation status of patients with NSCLC, detected by histological examination and ARMS PCR. EGFR mutation status of patients with NSCLC, detected.

Fig. 5 Local gel scaffold for T cell memory response.

Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome Xiongjie Jin, Demetrius.

Depletion of Drosha in the endothelium in mice results in embryonic developmental vascular abnormalities similar to HHT. Depletion of Drosha in the endothelium.

Fig. 3 Hepatic HBV envelope RNA and protein expression levels in HBVRplRag−/− mice 7 days (1 week) and 8 to 24 weeks after adoptive transfer with WT or.

Fig. 4. Features of PH in LLC1 lung tumor mice.

Fig. 2 Adoptive transfer of adult Ox40−/− splenocytes into adult HBVEnvRag−/− mice alters hepatic inflammation, HBsAg clearance, HBsAb seroconversion,

Bexarotene is neuroprotective in mouse and human HD neurons in vitro

Fig. 4. Acute lung injury in miR-223−/y mice.

Fig. 1 Schematic of experimental design.

NRP1-expressing myeloid cells influence adipocyte hypertrophy, development of fatty liver, and CLSs. NRP1-expressing myeloid cells influence adipocyte.

Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.

Fig. 2. CD treatment facilitates regression of murine atherosclerosis.

Fig. 6 Transmissibility of adiposity from humanized mice to germ-free recipients. Transmissibility of adiposity from humanized mice to germ-free recipients.

BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations.

GLUT4 LXRE is required for downregulation of adipose GLUT4 mRNA during fasting and diet-induced obesity. GLUT4 LXRE is required for downregulation of adipose.

MϕRIP140KD mice show browning in vWAT.

Liver fibrosis after CCl4 injury in 5αR1-KO and WT mice.

Fig. 5. Col IV–Ac2-26 NPs decrease lesion area, necrotic area, and oxidative stress in brachiocephalic arterial plaques. Col IV–Ac2-26 NPs decrease lesion.

AP2-Cre–mediated IKKβ deletion results in similar defects in adipose remodeling and accentuated inflammatory responses after HF feeding. aP2-Cre–mediated.

IKKβ protects adipocytes from HFD-induced cell death.

Fig. 1. Matrix stiffness sensitizes myofibroblasts to apoptosis induced by inhibition of their mechanotransduction pathways. Matrix stiffness sensitizes.

Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.

Fig. 3 Mmp-2−/− mice are protected from obesity and leptin resistance.

Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.

Glial cell line-derived neurotrophic factor (GDNF) is upregulated in mouse liver fibrosis. Glial cell line-derived neurotrophic factor (GDNF) is upregulated.

Fig. 3. Effects of SFN in mice with diet-induced diabetes.

Presentation transcript:

Fig. 1. NASH and fibrosis develop late in mice fed an HFD. NASH and fibrosis develop late in mice fed an HFD. Mice were maintained on a normal diet (filled symbols; ND) or a 60% kcal from fat diet (open symbols; HFD) for 15 (circles) or 40 (squares) weeks. (A) Body weights and liver weight and liver index (% of body weight) were collected (n = 10 to 20). Characteristics of NASH were measured including isolated liver leukocyte counts (n = 9 to 12) (B), serum ALT and aspartate aminotransferase (AST) (n = 9 to 10) (C), and steatosis by Oil Red O staining (D). Scale bars, 100 μm. (E) Liver sections were stained with keratin 8/18 and ubiquitin (Ub.) to assess hepatocyte ballooning and hematoxylin and eosin (H&E) for hepatic inflammation (inset showing example of lobular inflammation). Scale bars, 40 μm. (F) Picrosirius red staining was performed to assess fibrotic collagen deposition (scale bars, 200 μm) and viewed under polarized light to enhance visualization (inset scale bars, 200 μm). Adipose inflammation was assessed from Giemsa-stained sections from 40-week–treated animals (scale bars, 150 μm) (G), crown-like structures marked with arrows, expression of tnf (H) (n = 4 to 5), and flow cytometry analysis of Siglec-F+ adipose eosinophils among CD45 leukocytes (I) (n = 5 to 12). All data points represent a single mouse, and representative or pooled data from two or more independent experiments are shown (two-tailed t tests, n = 2 to 10; *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001). Kevin M. Hart et al., Sci Transl Med 2017;9:eaal3694 Published by AAAS